Producer of respiratory therapy solutions, including albuterol sulfate, racepinephrine, and sodium chloride inhalation solutions. Products are sold to hospitals and wholesalers. The bulk of revenue is derived from activity in the pharmaceuticals industry. This company was capitalized by private investment. International sales but percent of sales unknown. Products include racepinephrine inhalation solutions, Sodium chloride inhalation solutions, Albuterol sulfate inhalation solutions.